Physician profile
Nagendra S Koneru
NPI 1508989260
$29,417.01
in general payments reported to CMS, 2019-2025
20 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $55.64 · 2021: $2,319 · 2022: $34.23 · 2023: $3,006 · 2024: $6,822 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Travel and Lodging: $3,108 · Food and Beverage: $1,899 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,325.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Travel and Lodging | $3,108.24 |
| Food and Beverage | $1,898.55 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13,575.33 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $8,648.28 | 2021-2025 | Truebeam, Vitalbeam, Eclipse Treatment Planning System For External Beam Radiation Therapy |
| Reflexion Medical, INC. | $2,799.90 | 2021-2025 | Reflexion Medical Radiotherapy System |
| Astrazeneca Pharmaceuticals Lp | $1,890.00 | 2021 | |
| Isoray, INC | $1,010.39 | 2019-2024 | Brachytherapy Source |
| Elekta, INC. | $460.03 | 2023-2025 | Elekta Medical Linear Accelerator, Elekta Unity |
| Astellas Pharma US INC | $295.12 | 2022-2025 | Xtandi, Padcev |
| Tempus Ai, INC | $148.55 | 2024-2025 | Xt Cdx |
| Varian Medical Systems, INC. | $107.19 | 2019-2020 | |
| Boston Scientific Corporation | $80.46 | 2019 | |
| Merck Sharp & Dohme LLC | $78.70 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $62.49 | 2024-2025 | Ojjaara, Blenrep, Jemperli |
| Novocure INC. | $55.86 | 2023-2025 | Optune Lua (Novottf-200t), Optune |
| Daiichi Sankyo INC. | $52.49 | 2024 | Injectafer |
| Jazz Pharmaceuticals INC. | $39.27 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $29.90 | 2024 | |
| Incyte Corporation | $28.81 | 2025 | Jakafi |
| Abbvie INC. | $23.08 | 2023 | |
| Janssen Biotech, INC. | $17.50 | 2024 | Erleada, Rybrevant |
| G1 Therapeutics, INC. | $13.66 | 2023 | Cosela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nagendra Koneru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.